Related Experiment Video
Updated: May 3, 2026
10:02
Intra-Peritoneal Transplantation for Generating Acute Myeloid Leukemia in Mice
Published on: January 6, 2023
2.1K
BCR-ABL1-positive microvesicles transform normal hematopoietic transplants through genomic instability: implications
1Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China.
Leukemia
|February 1, 2014
Summary
Leukemia cell microvesicles carrying BCR-ABL1 mRNA can transform normal cells, causing genomic instability and promoting donor cell leukemia (DCL). These microvesicles offer a model for studying leukemogenesis and detecting DCL.
Area of Science:
- Hematology
- Molecular Biology
- Oncology
Background:
- Donor cell leukemia (DCL) can arise from malignant transformation of hematopoietic transplants by residual leukemia cells.
- Leukemia cell-derived microvesicles (MVs) are implicated in this transformation process.
- The specific role of MVs in inducing DCL and their underlying mechanisms require further investigation.
Purpose of the Study:
- To investigate the role of leukemia cell-derived microvesicles (MVs) in the malignant transformation of normal hematopoietic transplants.
- To elucidate the mechanisms by which MVs induce genomic instability and promote leukemogenesis.
- To evaluate the potential of MVs as diagnostic and preventive tools for DCL.
Main Methods:
- Isolation and characterization of MVs from K562 leukemia cells.
- Incubation of normal mononuclear cells with BCR-ABL1-positive MVs.
- In vitro and in vivo assessment of malignant transformation.
- Analysis of genomic instability, DNA damage, and methylation patterns in recipient cells.
Main Results:
- BCR-ABL1-positive MVs transferred BCR-ABL1 mRNA into recipient cells, inducing a leukemia-like malignant phenotype.
- MVs caused genomic instability in recipient cells through activation-induced cytidine deaminase and reactive oxygen species, leading to DNA damage.
- MVs also induced global DNA hypermethylation via upregulation of methyltransferases.
- BCR-ABL1-positive MVs initiated malignant transformation of normal hematopoietic transplants via genomic instability.
Conclusions:
- Leukemia cell-derived MVs carrying BCR-ABL1 mRNA can induce malignant transformation of normal hematopoietic transplants.
- Genomic instability, mediated by DNA damage and aberrant methylation, is a key mechanism in MV-induced leukemogenesis.
- BCR-ABL1-positive MVs provide a valuable model for studying DCL and may serve as early indicators for DCL detection and prevention.
